It is anticipated that this review will serve as a platform for future research that aims to explore the molecular mechanisms underlying TDP-43’s relationship with immunity and inflammation in the pathogenesis of neurodegeneration in ALS and FTD, potentially providing novel therapeutic targets. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.